4,784
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Gene Therapies to Reduce Chronic Pain: Are we There Yet?

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 209-212 | Received 17 Apr 2020, Accepted 28 Apr 2020, Published online: 17 Jun 2020
 

Financial & competing interests disclosure

All authors are employees of Navega Therapeutics. Patents related to this study have been submitted. This work was partially supported by NIH grants R43CA239940-01 and R43NS112088-01A1. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

All authors are employees of Navega Therapeutics. Patents related to this study have been submitted. This work was partially supported by NIH grants R43CA239940-01 and R43NS112088-01A1. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.